N-[1-[3-(2,6-diphenylpyrimidin-4-yl)benzenecarboximidoyl]naphthalen-2-yl]pyridin-4-amine
C38H27N5 — CID 152976135
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[3-(2,6-diphenylpyrimidin-4-yl)benzenecarboximidoyl]naphthalen-2-yl]pyridin-4-amine
N-[1-[3-(2,6-diphenylpyrimidin-4-yl)benzenecarboximidoyl]naphthalen-2-yl]pyridin-4-amine (PubChem CID 152976135) has the molecular formula C38H27N5 and a molecular weight of 553.67 g/mol. Its IUPAC name is N-[1-[3-(2,6-diphenylpyrimidin-4-yl)benzenecarboximidoyl]naphthalen-2-yl]pyridin-4-amine.
Molecular Properties
| Compound Name | N-[1-[3-(2,6-diphenylpyrimidin-4-yl)benzenecarboximidoyl]naphthalen-2-yl]pyridin-4-amine |
|---|---|
| PubChem CID | 152976135 |
| Molecular Formula | C38H27N5 |
| Molecular Weight | 553.67 g/mol |
| Exact Mass | 553.23 |
| IUPAC Name | N-[1-[3-(2,6-diphenylpyrimidin-4-yl)benzenecarboximidoyl]naphthalen-2-yl]pyridin-4-amine |
| SMILES | [H]/N=C(\c1cccc(-c2cc(-c3ccccc3)nc(-c3ccccc3)n2)c1)c1c(Nc2ccncc2)ccc2ccccc12 |
| InChI | InChI=1S/C38H27N5/c39-37(36-32-17-8-7-10-26(32)18-19-33(36)41-31-20-22-40-23-21-31)30-16-9-15-29(24-30)35-25-34(27-11-3-1-4-12-27)42-38(43-35)28-13-5-2-6-14-28/h1-25,39H,(H,40,41)/b39-37+ |
| InChIKey | UTLJMCVMXAVEJU-NHFVQZBWSA-N |
| XLogP | 9.19 |
| TPSA | 74.55 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 553.67 |
| LogP ≤ 5 | 9.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 152976135 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.